An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.

This month marks the one-year anniversary of the London Declaration—an unprecedented pledge by a group of public and private partners to control or eliminate 10 NTDs by 2020. This includes an uptick in drug donations, research and development and bilateral support for NTD programs around the world.

The BRICS countries ― Brazil, Russia, India, China, and South Africa ― are a group of emerging economies distinguished by their growing influence in regional and global affairs.

Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.